Ultomiris

Medicinal product

(Invented) name

Ultomiris

Active substance (s)

Ravulizumabas

Strength

300 mg/30 ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AJ02, ravulizumab

Marketing authorisation holder

Alexion Europe SAS, Prancūzija

Date of authorisation

2019-07-02

Date of renewal

Documents

Ultomiris mokomoji medziaga pacientams_tevams_globejams.pdf

Ultomiris mokomoji medziaga sveikatos prieziuros specialistams.pdf

Ultomiris paciento kortele.pdf

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	30 ml
Ravulizumabas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102161	88262	1088262	flakonas	30 ml N1		Receptinis	EU/1/19/1371/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-08-18	Išregistruotas
2019-07-02	Registruotas